Byeong H. Min
Chuncheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Multistrain Probiotics Alleviate Diarrhea by Modulating Microbiome-Derived Metabolites and Serotonin Pathway.
Journal: Probiotics and antimicrobial proteins
Published: February 02, 2024
Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation.
Journal: Gut microbes
Published: February 01, 2024
Multi-strain probiotics alleviate loperamide-induced constipation by adjusting the microbiome, serotonin, and short-chain fatty acids in rats.
Journal: Frontiers in microbiology
Published: February 27, 2023
Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis.
Journal: Frontiers in microbiology
Published: December 22, 2022
Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease.
Journal: Foods (Basel, Switzerland)
Published: July 20, 2022
The identification of metabolites from gut microbiota in NAFLD via network pharmacology.
Journal: Scientific reports
Published: July 05, 2022
The Link between Gut Microbiota and Hepatic Encephalopathy.
Journal: International journal of molecular sciences
Published: July 05, 2022
The Lactobacillus as a Probiotic: Focusing on Liver Diseases.
Journal: Microorganisms
Published: January 04, 2022
Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease.
Journal: Clinical and translational medicine
Published: June 03, 2021
Diet-Regulating Microbiota and Host Immune System in Liver Disease.
Journal: International journal of molecular sciences
Published: May 28, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026